Exact Mass: 305.0123

Exact Mass Matches: 305.0123

Found 37 metabolites which its exact mass value is equals to given mass value 305.0123, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Isoimide

N-(Bromophenyl)-3,4,5,6-tetrahydroisophthalimide

C14H12BrNO2 (305.0051)


   

Imide

N-(4-Bromophenyl)-3,4,5,6-tetrahydrophthalimide

C14H12BrNO2 (305.0051)


   

AS-252424

5-[5-(4-fluoro-2-hydroxy-phenyl)-furan-2-ylmethylene]-thiazolidine-2,4-dione

C14H8FNO4S (305.0158)


   

10H-Phenothiazine,3,7-dinitro-, 5-oxide

10H-Phenothiazine,3,7-dinitro-, 5-oxide

C12H7N3O5S (305.0106)


   

4-Bromo-2-methoxy-N-phenylbenzamide

4-Bromo-2-methoxy-N-phenylbenzamide

C14H12BrNO2 (305.0051)


   

2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline

2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline

C14H9Cl2N3O (305.0123)


   

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

BENZYL 4-BROMOPHENYLCARBAMATE

BENZYL 4-BROMOPHENYLCARBAMATE

C14H12BrNO2 (305.0051)


   

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

N-CHLOROACETYL-3,5-BIS(TRIFLUOROMETHYL)ANILINE

C10H6ClF6NO (305.0042)


   

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

n-t-butyl 3-bromo-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

N-(4-bromophenyl)-4-methoxy-benzamide

N-(4-bromophenyl)-4-methoxy-benzamide

C14H12BrNO2 (305.0051)


   

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID

C14H12BrNO2 (305.0051)


   

2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine

2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine

C13H12BrN3O (305.0164)


   

3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid

C11H7ClF3N3O2 (305.0179)


   

2-Bromo-N-pentylbenzenesulfonamide

2-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

4-BROMO-3-METHOXY-N-PHENYLBENZAMIDE

C14H12BrNO2 (305.0051)


   

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester

C14H12BrNO2 (305.0051)


   

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER

C11H16BrNO2S (305.0085)


   

4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID

4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID

C14H11NO3S2 (305.018)


   

Benzyl 2-amino-5-bromobenzoate

Benzyl 2-amino-5-bromobenzoate

C14H12BrNO2 (305.0051)


   

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

5-bromo-N-(tert-butyl)-2-Methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

2-BOC-AMINO-3,5-DICHLOROBENZOIC ACID

2-BOC-AMINO-3,5-DICHLOROBENZOIC ACID

C12H13Cl2NO4 (305.0222)


   

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

2-(4-Chloro-3-nitrobenzoyl)benzoic acid

C14H8ClNO5 (305.0091)


   

3-Bromo-N-butyl-5-methylbenzenesulfonamide

3-Bromo-N-butyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

3-Bromo-N-(tert-butyl)-N-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

3-bromo-N,N-diethyl-4-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

3-Bromo-N,N-diethyl-5-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

4-Bromo-N,N-diethyl-3-methylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

N-BUTYL 3-BROMO-4-METHYLBENZENESULFONAMIDE

C11H16BrNO2S (305.0085)


   

3-Bromo-N-pentylbenzenesulfonamide

3-Bromo-N-pentylbenzenesulfonamide

C11H16BrNO2S (305.0085)


   

2,3-cyclic UMP(1-)

2,3-cyclic UMP(1-)

C9H10N2O8P- (305.0175)


A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.

   

2-bromo-N-(3-methoxyphenyl)benzamide

2-bromo-N-(3-methoxyphenyl)benzamide

C14H12BrNO2 (305.0051)


   

5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione

5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione

C14H8FNO4S (305.0158)


   

5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester

5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester

C14H11NO3S2 (305.018)


   

Cyclic 35-uridine monophosphate

Cyclic 35-uridine monophosphate

C9H10N2O8P- (305.0175)


   

Taminadenant

Taminadenant

C10H8BrN7 (305.0025)


Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].